top of page
ABOUT
Polybiomics is revolutionizing the analysis of live cells.
Our innovative technology and proprietary process enables simultaneous measurements of multiple cellular features from the same sample in real-time. Our analytics connects multiple data types to create new knowledge and derive deep actionable insights, currently unattainable. This accelerates discovery and product development in pharma and clinic, and positions Polybiomics at the forefront of a multi-billion dollar market.
SOLUTIONS
THE POLYBIOMICS SOLUTION
Polybiomics is offering a disruptive live cell analysis platform for drug discovery and development, enabling the use of a single-instrument to generate interlinked datasets through multimodal testing of a single sample under constant conditions. Our solution uses AI to create actionable insights and predict outcomes, saving sims, costs, and protecting sample integrity.
Integrated System
and Consumable
PolyData™
and Analytics
Actionable
Intelligence
OUR TEAM
LEADERSHIP
Mandana Veiseh, PhD
Founder, President, CSTO
Bahram Bahrami, PhD
Co-founder, CEO
TEAM
David Stumbo, PhD
Shahab S. Bahaei, PhD
Ava Aslanpour, BE
Kayla Solomon, BS
Bob Smith-McCollum, MBA
Navya Mangipudi
David Duhl, PhD
SCIENTIFIC ADVISORY
Mina J Bissell, PhD
National Academy Member
Kurt Petersen, PhD
National Academy Member
Ron W Davis, PhD
National Academy Member
Rick Horwitz, PhD
ADVISORS
Darren Cooke, JD
Natalie Wisniewski, PhD
Pirooz Parvarandeh, MS
Jeff Hartlin, JD
Sandeep Sheriff, CPA
TEAM
bottom of page